Submissions from 2025
“Diabetes and Kidneys: Unraveling T2D’s Silent Threat”, Radica Alicic
“Diabetes and Kidneys: Unraveling T2D’s Silent Threat”, Radica Alicic
Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions., Radica Alicic and Joshua J Neumiller
Incidence of chronic kidney disease among adults with prediabetes in the CURE-CKD registry, 2013-2020., Radica Z Alicic, Obidiugwu K Duru, Cami R Jones, Lindsey M Kornowske, Kenn B Daratha, Christina L Reynolds, Meda E Pavkov, Alain K Koyama, Fang Xu, Susanne B Nicholas, Joshua J Neumiller, Keith C Norris, Kelly A Hennessey, and Katherine R Tuttle
Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease., Radica Z Alicic, Joshua J Neumiller, and Katherine R Tuttle
Two decades of nephrology research: progress and future challenges., Urmila Anandh, Hans-Joachim Anders, Justine Bacchetta, David W Johnson, Valerie Luyckx, Giuseppe Remuzzi, Bernardo Rodriguez-Iturbe, Katalin Susztak, Katherine Tuttle, and Motoko Yanagita
Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6., Ellen M Apperloo, David Z I Cherney, Anja Birk Kuhlman, Johannes F E Mann, Søren Rasmussen, Peter Rossing, Katherine R Tuttle, Blaz Vrhnjak, and Hiddo J L Heerspink
Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1-5 Clinical Trials., Ellen M Apperloo, Katherine Tuttle, Imre Pavo, Axel Haupt, Rebecca Taylor, Russell J Wiese, Andrea Hemmingway, David Z I Cherney, Naveed Sattar, and Hiddo J L Heerspink
Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1-5 Clinical Trials., Ellen M Apperloo, Katherine Tuttle, Imre Pavo, Axel Haupt, Rebecca Taylor, Russell J Wiese, Andrea Hemmingway, David Z I Cherney, Naveed Sattar, and Hiddo J L Heerspink
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials., Sunil V Badve, Anika Bilal, Matthew M Y Lee, Naveed Sattar, Hertzel C Gerstein, Christian T Ruff, John J V McMurray, Peter Rossing, George Bakris, Kenneth W Mahaffey, Johannes F E Mann, Helen M Colhoun, Katherine Tuttle, Richard E Pratley, and Vlado Perkovic
Using guideline-directed medical therapies to improve kidney and cardiovascular outcomes in patients with chronic kidney disease., Thelma Barber, Joshua J Neumiller, Michelle A Fravel, Robert L Page, and Katherine R Tuttle
Impact the Utilization of Evidenced Based Practices has on Post Kidney Transplant Patient Outcomes, Judith Bautista, Vicky Loren Dela Cruz, Ervieneth Martin, Jennifer Mauricio, and Alf Bernardino
Prevalence and Associations of Systemic Inflammation in Heart Failure Across the Spectrum of Ejection Fraction., Barry A Borlaug, Cecilie Holse, Mette Holme Jung, A Michael Lincoff, Sharon L Mulvagh, Jacob Stærk-Østergaard, Katherine R Tuttle, and Mark C Petrie
Associations between donor-derived cell-free DNA dynamics and clinical outcomes after kidney allograft rejection: A prospective, multicenter study., Suphamai Bunnapradist, Nicolae Leca, Ziad S Zaky, Robert J Stratta, Hasan A Khamash, Fuad Shihab, Obi Ekwenna, Martin Aldana-Campos, Joseph Kahwaji, Luigi Biancone, Thin Thin Maw, D Giovanni Biagini, Navchetan Kaur, Adam Prewett, Geethanjali Gude, Paul Van Hummelen, Michelle S Bloom, Zachary Demko, Matthew Rabinowitz, Steven L Chapman, Phil Gauthier, Sangeeta Bhorade, Hossein Tabriziani, Yasir Qazi, and PEDAL investigators
Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance: cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study., Dominic Ehrmann, Heidi Krause-Steinrauf, Diane Uschner, Hui Wen, Claire J Hoogendoorn, Gladys Crespo-Ramos, Caroline Presley, Valerie L Arends, Robert M Cohen, W Timothy Garvey, Thomas Martens, Holly J Willis, Andrea Cherrington, Jeffrey S Gonzalez, GRADE Research Group, Frances E. Broyles, and Warren L. Fein
Antibiotic Lock Therapy fpr Dialysis Catheters: Implementation at an Urban Hospital, Erik Enquist, Hilary Klastae, and Mary Jo Kelly
Continuous glucose monitoring improves detection of glycemic excursions in hemodialysis patients with type 2 diabetes., Rodolfo J Galindo, Bobak Moazzami, Amany Gerges, Ina Flores, Giuliana Arevalo, Limin Peng, Katherine R Tuttle, and Guillermo E Umpierrez
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial., Hiddo J L Heerspink, Rajiv Agarwal, George L Bakris, David Z I Cherney, Carolyn S P Lam, Brendon L Neuen, Pantelis A Sarafidis, Katherine R Tuttle, Christoph Wanner, Meike D Brinker, Sara Dizayee, Peter Kolkhof, Patrick Schloemer, Paula Vesterinen, Vlado Perkovic, and FIND-CKD investigators
Outcomes of endoscopic management for upper tract urothelial carcinoma: A multi-center international cohort analysis., Jaime O Herrera-Caceres, Marian Wettstein, Surena F Matin, Craig Labbate, Aaron Potretzke, Rodrigo Rodriguez, Nirmish Singla, Maximilian Pallauf, William Huang, Shavy Nagpal, Nir Kleinmann, Asaf Shvero, Alexander Small, Benjamin Green, Jennifer Linehan, Jane Choe, Ojas Shah, Arun Rai, Hristos Kaimakliotis, Isamu Tachibana, David Canes, Aaron Perecman, and Jay D Raman
Trends in Pharmacological Treatment of Patients With New Onset Type 2 Diabetes: Usage Patterns in an Evolving Guideline Landscape., William Hou, Katherine R Tuttle, Weining Shen, Andrew Reikes, and Jonathan H Watanabe
Comparative Risk of Adverse Pancreatic Events With GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP4 Inhibitors, and Sulfonylureas Among Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk., Urja N Kalathiya, Jeph Herrin, Kavya Sindu Swarna, Yihong Deng, Eric C Polley, Joshua J Neumiller, Rodolfo J Galindo, Guillermo E Umpierrez, Joseph S Ross, Mindy M Mickelson, and Rozalina G McCoy
SGLT2 inhibitors and nephrolithiasis risk: a meta-analysis., Mehmet Kanbay, Crischentian Brinza, Sidar Copur, Ozge Sekreter, Alexandru Burlacu, Katherine Tuttle, Peter Rossing, and Adrian Covic
Impact of weight change on kidney transplantation outcomes: A systematic review and meta-analysis., Mehmet Kanbay, Dimitrie Siriopol, Sama Mahmoud Abdel-Rahman, Zeynep Y Yilmaz, Lasin Ozbek, Mustafa Guldan, Sidar Copur, and Katherine Tuttle
Worsening Renal Function Is Common and Is Associated With Higher Mortality Rates in Cardiogenic Shock: A Cardiogenic Shock Working Group Report., Rachna Kataria, Shashank S Sinha, Song Li, Qiuyue Kong, Manreet Kanwar, Jaime Hernandez-Montfort, A Reshad Garan, Jacob Abraham, Elric Zweck, VAN-Khue Ton, David M Dudzinski, Anthony Faugno, Maryjane Farr, Esther Vorovich, Shelley Hall, Maya Guglin, Mohit Pahuja, Kevin John, Ajar Kochar, Vanessa Blumer, Saraschandra Vallabhajosyula, Sandeep Nathan, Neil M Harwani, Gavin W Hickey, Andrew D Schwartzman, Wissam Khalife, Claudius Mahr, Ju H Kim, Arvind Bhimaraj, Paavni Sangal, Karol D Walec, Peter Zazzali, Justin Fried, Daniel Burkhoff, and Navin K Kapur
Glycemic Management and Individualized Diabetes Care in Dialysis-Dependent Kidney Failure., Klara R Klein, Ildiko Lingvay, Katherine R Tuttle, and Jennifer E Flythe
Mind the gap in kidney care: translating what we know into what we do., Valerie A Luyckx, Katherine Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, and Alessandro Balducci
Mind the gap in kidney care: Translating what we know into what we do., Valerie A Luyckx, Katherine Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, and Alessandro Balducci
Perceptions of high-sensitivity C-reactive protein testing (hsCRP) in atherosclerotic cardiovascular disease: a US survey on cardiologists and nephrologists., Lei Lv, Tyler J Gluckman, Matthew Strum, and Jigar Rajpura
Prevalence and clinical characteristics of patients with hsCRP testing and test-confirmed systemic inflammation among individuals with atherosclerotic cardiovascular disease with or without chronic kidney disease in the United States (PLUTUS)., Lei Lv, Jigar Rajpura, Meixia Liu, Matt Strum, Benjamin Chastek, Jonathan Johnson, and Tyler J Gluckman
Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial., Kenneth W Mahaffey, Katherine R Tuttle, Mustafa Arici, Florian M M Baeres, George Bakris, David M Charytan, David Z I Cherney, Gil Chernin, Ricardo Correa-Rotter, Janusz Gumprecht, Thomas Idorn, Giuseppe Pugliese, Ida Kirstine Bull Rasmussen, Søren Rasmussen, Peter Rossing, Ekaterina Sokareva, Johannes F E Mann, Vlado Perkovic, and Richard Pratley
Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trial., Mahmoud B Malas, Mohammed Hamouda, Alik Farber, Matthew T Menard, Michael S Conte, Kenneth Rosenfield, Michael B Strong, Gheorghe Doros, Richard J Powell, Carlos Mena-Hurtado, Warren Gasper, Marc L Schermerhorn, Sara Allievi, Kim G Smolderen, Michael D Dake, Jennifer A Rymer, and Katherine Tuttle
Clinical characteristics and CKD care delivery in African American and American Indian or Alaska Native patients: A real-world cohort study., Kiara N Mayhand, Radica Z Alicic, Lindsey M Kornowske, Cami R Jones, Kenn B Daratha, Christina L Reynolds, Susanne B Nicholas, Roland J Thorpe, Alex A T Bui, Keith C Norris, and Katherine R Tuttle
Systemic Inflammation and the Risks of Adverse Kidney Outcomes in Adults With Atherosclerotic Cardiovascular Disease., Faizan Mazhar, Edouard L Fu, Anne-Laure Faucon, Paul Hjemdahl, Jimmi Mathisen, Iram Faqir Muhammad, Oscar Plunde, Vlado Perkovic, Katherine Tuttle, and Juan-Jesus Carrero
A structured training curriculum for robot-assisted radical nephroureterectomy: a Delphi consensus study., Farshad Sheybaee Moghaddam, Alireza Ghoreifi, Rashid K Sayyid, Zhenjie Wu, Firas Abdollah, Alessandro Antonelli, Daniel D Eun, Shengjie Guo, Andrew J Hung, Lulin Ma, Vitaly Margulis, Surena F Matin, Reza Mehrazin, James R Porter, Aaron Potretzke, Benjamin Pradere, Morgan Roupret, Thomas Seisen, Shahrokh F Shariat, Giuseppe Simone, Robert J Stein, Long Wang, Jitao Wu, Evanguelos Xylinas, Lin Yao, Homayoun Zargar, Riccardo Autorino, Giovanni E Cacciamani, and Hooman Djaladat
Extending Kidney Protective Therapy to Type 1 Diabetes: The Time is Now., Joshua J Neumiller and Katherine R Tuttle
Population risk predictors of major adverse kidney events attributed to focal segmental glomerulosclerosis from the CURE-CKD registry., Susanne B Nicholas, Lindsey M Kornowske, Cami R Jones, Kenn B Daratha, Radica Z Alicic, Christina L Reynolds, Joshua J Neumiller, Mark E Bensink, Wu Gong, Keith C Norris, and Katherine R Tuttle
Population Risk Predictors of Major Adverse Kidney Events in Patients with Focal Segmental Glomerulosclerosis from the CURE-CKD Registry., Susanne B Nicholas, Lindsey M Kornowske, Cami R Jones, Kenn B Daratha, Radica Z Alicic, Christina L Reynolds, Joshua J Neumiller, Mark E Bensink, Wu Gong, Keith C Norris, and Katherine R Tuttle
Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference., Alberto Ortiz, José Manuel Arreola Guerra, Juliana C N Chan, Vivekanand Jha, Holly Kramer, Susanne B Nicholas, Meda E Pavkov, Christoph Wanner, Leslie P Wong, Michael Cheung, Jennifer M King, Morgan E Grams, Michel Jadoul, and Katherine Tuttle
Cardiovascular, kidney, and metabolic health: an actionable vision for heart failure prevention., John W Ostrominski, Alice Y Y Cheng, Adam J Nelson, Brendon L Neuen, Naveed Sattar, Katherine Tuttle, and Muthiah Vaduganathan
Response to the letter to the editor entitled "Semaglutide and kidney function: direct kidney protection or an artifact?"., Vlado Perkovic, Katherine R Tuttle, Peter Rossing, Johannes F E Mann, and Thomas Idorn
Long-term efficacy of 10 kHz spinal cord stimulation in managing painful diabetic neuropathy: A post-study survey., Erika A Petersen, Shawn M Sills, Thomas G Stauss, Rose Province-Azalde, Michael J Jaasma, Deborah R Edgar, Judith L White, James A Scowcroft, Cong Yu, Jijun Xu, Maged N Guirguis, Kasra Amirdelfan, David J DiBenedetto, Ali Nairizi, Shivanand P Lad, Neel D Mehta, Dawood Sayed, Khalid A Sethi, Sarah Benducci, and Manish Bharara
Adoption of Single-Port Robotic Partial Nephrectomy Increases Utilization of the Retroperitoneal Approach: A Report from the Single-Port Advanced Research Consortium., Michael Raver, Mutahar Ahmed, Kennedy E Okhawere, Indu Saini, Ruchir Chaturvedi, Milan Patel, Ruben Sauer Calvo, Nicolas A Soputro, Roxana Ramos, Mubashir Billah, Simone Crivellaro, Ahmed M Mansour, Jihad Kaouk, Nirmish Singla, James Porter, Ronney Abaza, Akshay Bhandari, Ashok K Hemal, Phillip M Pierorazio, Benjamin I Chung, Craig G Rogers, Reza Mehrazin, Ketan Badani, and Michael Stifelman
Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement., Stefano Romeo, Antonio Vidal-Puig, Mansoor Husain, Rexford Ahima, Marcello Arca, Deepak L Bhatt, Anna Mae Diehl, Luigi Fontana, Roger Foo, Gema Frühbeck, Julia Kozlitina, Eva Lonn, Francois Pattou, Jogchum Plat, Susan E Quaggin, Paul M Ridker, Mikael Rydén, Nicola Segata, Katherine R Tuttle, Subodh Verma, Jeanine Roeters van Lennep, Marianne Benn, Christoph J Binder, Oveis Jamialahmadi, Rosie Perkins, Alberico L Catapano, Lale Tokgözoğlu, Kausik K Ray, and European Atherosclerosis Society Consensus
Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis., Peter Rossing, George Bakris, Vlado Perkovic, Richard Pratley, Katherine R Tuttle, Kenneth W Mahaffey, Thomas Idorn, Nicolas Belmar, Heidrun Bosch-Traberg, Søren Rasmussen, Robert S Busch, Ronald E Schmieder, Pieter Gillard, Johannes F E Mann, and FLOW Investigator Group
WCN25-2620 CUMULATIVE EFFECTS OF THE ALDOSTERONE SYNTHASE INHIBITOR VICADROSTAT COMBINED WITH EMPAGLIFLOZIN ON ALBUMINURIA IN PEOPLE WITH CKD, Peter Rossing, Katherine Tuttle, and See full list of authors in comments
Outcomes Of Patients With Advanced Chronic Kidney Disease And A Pulmonary Artery Pressure Sensor: Insights From The HF2 Registry, Mason Sanders, Elizabeth Volz, Kartik Munshi, Terrie Ann Benjamin, Mosi Bennett, Pranathi Pilla, Kunjan Bhatt, Arvind Bhimaraj, Timothy Fendler, Marat Fudim, Maya Guglin, Ashrith Guha, J. Thomas Heywood, Orvar Jonsson, Liviu Klein, Patrick McCann, Monique Robinson, Andrew Sauer, Hsin-Fang Li, Hirak Shah, and Jacob Abraham
Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial., Stacey M Sklepinski, Yihong Deng, Kavya Sindu Swarna, Jeph Herrin, Eric C Polley, Joshua J Neumiller, Rodolfo J Galindo, Guillermo E Umpierrez, Joseph S Ross, Bijan J Borah, Bradley A Maron, Mindy M Mickelson, and Rozalina G McCoy
Health Disparity Clusters of Off Label Prescriptions for Glucagon-Like Peptide 1 Receptor Agonists., Kateri J Spinelli, Allison H Oakes, Shih-Ting Chiu, Mary T Imboden, Austin Miller, Sanjula Jain, and Ty J Gluckman
Indexing GFR Using Extracellular Volume versus Body Surface Area in a Population with Type 1 Diabetes and Diabetic Kidney Disease., Vikas S Sridhar, Luxcia Kugathasan, Leif Erik Lovblom, Ni Huajing, Sebastien O Lanctot, David M Maahs, Petter Bjornstad, M Luiza Caramori, Sylvia E Rosas, Peter Rossing, Katherine R Tuttle, Rodica Pop-Busui, Sarit Polsky, Amy B Karger, Chunyi Wu, Andrzej T Galecki, Bruce A Perkins, Michael Mauer, Alessandro Doria, and David Z I Cherney
Adding New Agents to Treatment Protocols for Patients with CKD, Katherine Tuttle
Adding New Agents to Treatment Protocols for Patients with CKD, Katherine Tuttle
Better Kidney Health, Katherine Tuttle
Cardiovascular-Kidney-Metabolic Syndrome. The Centrality of the Kidney, Katherine Tuttle
“Celebrating Dr. Steven Packer with those who know him well”, Katherine Tuttle
“Celebrating Dr. Steven Packer with those who know him well”, Katherine Tuttle
Evaluation of Chronic Kidney Disease, Katherine Tuttle
GLP 1 Receptor Agonism FLOWS into the Mainstream for Chronic Kidney Disease, Katherine Tuttle
GLP 1 Receptor Agonism FLOWS into the Mainstream for Chronic Kidney Disease, Katherine Tuttle
“Goal for Saving Kidneys, Hearts and Lives”, Katherine Tuttle
“Goal for Saving Kidneys, Hearts and Lives”, Katherine Tuttle
Interview with Katherine Tuttle and Jonathan Barratt, Katherine Tuttle
Interview with Katherine Tuttle and Jonathan Barratt, Katherine Tuttle
Outcomes of Critical Limb Threatening Ischemia Revascularization in Patients with Chronic Kidney Disease in the BEST - CLI Trial, Katherine Tuttle
Outcomes of Critical Limb Threatening Ischemia Revascularization in Patients with Chronic Kidney Disease in the BEST - CLI Trial, Katherine Tuttle
The Link between CKD and CVD, Katherine Tuttle
The Link between CKD and CVD, Katherine Tuttle
“Transforming CKD Care”, Katherine Tuttle
“Transforming CKD Care”, Katherine Tuttle
Why “K” Is in the Middle of Cardiovascular-Kidney-Metabolic Syndrome, Katherine Tuttle
A Real-World Cohort Study of the Risks of Kidney Failure and Death in Diabetes., Katherine Tuttle, Lindsey M Kornowske, Cami R Jones, Christina L Reynolds, Radica Alicic, Kenn Daratha, Joshua J Neumiller, O Kenrik Duru, Susanne B Nicholas, Keith C Norris, and Meda E Pavkov
Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review., Katherine R Tuttle, Linong Ji, Chantal Mathieu, and Jonathan Rosen
Population-Level Risk Factors for Kidney Outcomes in IgA Nephropathy: The CURE-CKD Registry., Katherine R Tuttle, Lindsey M Kornowske, Cami R Jones, Kenn B Daratha, Radica Z Alicic, Christina L Reynolds, Joshua J Neumiller, Mark E Bensink, Wu Gong, Keith C Norris, Susanne B Nicholas, and CURE-CKD Consortium
Dietary Advanced Glycation End Products and Cardiovascular-Kidney-Metabolic Complications., Jaime Uribarri and Katherine Tuttle
Kidney Function Decline in Incident Heart Failure Is a Surrogate Marker for Kidney Failure and Mortality., Carl P Walther, Katherine R Tuttle, and Sankar D Navaneethan
Effects of anti-inflammatory agents on clinical outcomes in people with chronic kidney disease: a systematic review and meta-analysis of randomized control trials., Emma R Webster, Adam Perkovic, Brendon L Neuen, Katherine R Tuttle, and Vlado Perkovic
State of Practice: ASNR Statement on Gadolinium-Based Contrast Agent Use in Patients with Chronic Kidney Disease., Kirk M Welker, David Joyner, Anthony W Kam, David S Liebeskind, Amit M Saindane, Colin Segovis, Noushin Yahyavi-Firouz-Abadi, and John E Jordan
Durability of response of UGN-101: Longitudinal follow up of multicenter study., Solomon L Woldu, Daniel Igel, Brett Johnson, Katie S Murray, Hiroko Miyagi, Wade Sexton, Isamu Tachibana, Hristos Kaimakliotis, Joseph Jacob, Rian Dickstein, Jennifer M Linehan, Alan Nieder, Marc A Bjurlin, Daniel Heidenberg, Mitchell Humphreys, Saum Ghodoussipour, Marcus L Quek, Michael O'Donnell, Brian H Eisner, Surena F Matin, Adam S Feldman, and Yair Lotan
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial., Junwen Zhou, Claire Williams, Natalie Staplin, Parminder K Judge, Kaitlin J Mayne, Nikita Agrawal, Ryoki Arimoto, Jennifer B Green, David Z I Cherney, Katherine Tuttle, Jose Leal, Philip Clarke, Jonathan R Emberson, David Preiss, Christoph Wanner, Martin J Landray, Colin Baigent, Richard Haynes, William G Herrington, and Borislava Mihaylova
The Autonomic Nervous System and Inflammation in Chronic Kidney Disease., Carmine Zoccali, Francesca Mallamaci, Mehmet Kanbay, Katherine R Tuttle, Peter Kotanko, Raffaele De Caterina, Guido Grassi, and Giuseppe Mancia
Submissions from 2024
Acute kidney injury in neonates with hypoxic ischemic encephalopathy based on serum creatinine decline compared to KDIGO criteria., Haejun C Ahn, Adam Frymoyer, Derek B Boothroyd, Sonia Bonifacio, Scott M Sutherland, and Valerie Y Chock
“GLP-1 Ras: On the Mechanisms of Renoprotection”, Radica Alicic
Role of GLP-1 and GIP/GLP-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions, Radica Alicic and JJ Neumiller
Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6., Ellen M Apperloo, David Z I Cherney, Anja Birk Kuhlman, Johannes F E Mann, Søren Rasmussen, Peter Rossing, Katherine Tuttle, Blaz Vrhnjak, and Hiddo J L Heerspink
Pre-Prediabetes: Insulin Resistance is Associated with Cardiometabolic Risk in Non-obese Patients (STOP DIABETES)., John P Armato, Ralph A DeFronzo, Muhammad Abdul-Ghani, and Ron Ruby
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial., Stefan R Bornstein, Dick de Zeeuw, Hiddo J L Heerspink, Friedrich Schulze, Lisa Cronin, Arne Wenz, Katherine Tuttle, Samy Hadjadj, and Peter Rossing
Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data., Athanasios Chamzas, Eglis Tellez, Andrew SyBing, Jogarao V S Gobburu, and Mathangi Gopalakrishnan
New and emerging therapies for diabetic kidney disease., Ricardo Correa-Rotter, Louise J Maple-Brown, Rakesh Sahay, Katherine R Tuttle, and Ifeoma I Ulasi
Combined Germline and Mosaic SDHA Mutation Is Associated With a Multicancer Syndrome Including Neuroblastoma, Renal Cancer, and Multifocal GI Tumor., Lee D Cranmer, Eric Q Konnick, Jennifer R Yoshida, Angela L Jacobson, Bilal A Malik, Harveshp Mogal, Lucas B Sullivan, Cynthia L Handfrod, Colin C Pritchard, and Marianne E Dubard-Gault
Development and validation of metrics for a new RAPN training model., Rui Jorge Dos Santos Almeida Farinha, Adele Piro, Angelo Mottaran, Marco Paciotti, Stefano Puliatti, Alberto Breda, James Porter, Ben Van Cleynenbreugel, Jos Vander Sloten, Alexandre Mottrie, RAPN-Delphi Surgeons Group, and Anthony G Gallagher
Diabetic Kidney Disease Prevention Care Model Development., Nuha A ElSayed, Raveendhara R Bannuru, George Bakris, Joan Bardsley, Ian H de Boer, Robert A Gabbay, Janet Gockerman, Rozalina G McCoy, Elaine McCracken, Joshua J Neumiller, Scott J Pilla, and Connie M Rhee
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial., EMPA-KIDNEY Collaborative Group and Katherine Tuttle (EMPA-KIDNEY Collaborative Group)
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial., EMPA-KIDNEY Collaborative Group and Katherine Tuttle (EMPA-KIDNEY Collaborative Group)
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial., EMPA-KIDNEY Collaborative Group and Katherine Tuttle
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial., EMPA-KIDNEY Collaborative Group and Katherine Tuttle
The authors reply., Winston W S Fung, Valerie A Luyckx, Katherine R Tuttle, and Writing team and the World Kidney Day Joint Steering Committee
The authors reply., Winston W S Fung, Valerie A Luyckx, Katherine R Tuttle, and World Kidney Day Joint Steering Committee
Continuous Glucose Monitoring Metrics and Hemoglobin A1c Relationship in Patients with Type 2 Diabetes Treated by Hemodialysis., Rodolfo J Galindo, Bobak Moazzami, Katherine R Tuttle, Richard M Bergenstal, Limin Peng, and Guillermo E Umpierrez
Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma., Shuchi Gulati, Pedro C Barata, Andrew Elliott, Mehmet Asim Bilen, Earle F Burgess, Toni K Choueiri, Sourat Darabi, Nancy Ann Dawson, Benjamin Adam Gartrell, Hans J Hammers, Elisabeth I Heath, Daniel Magee, Arpit Rao, Charles J Ryan, Przemyslaw W Twardowski, Shuanzeng Wei, James Brugarolas, Tian Zhang, Matthew R Zibelman, Chadi Nabhan, and Rana R McKay
